THE EFFICACY OF MOISTURIZERS IN RESTORING HYDRATION,SKIN pH, AND REDUCING TRANS-EPIDERMAL WATER LOSS(TEWL) IN PATIENTS WITH ATOPIC DERMATITIS - Trial PACTR202209711529835
Access comprehensive clinical trial information for PACTR202209711529835 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Lagos and is currently Recruiting. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Lagos
UNIVERSITY OF LAGOS
Timeline & Enrollment
Phase 2
Aug 01, 2022
Mar 31, 2023
Summary
Background: Atopic dermatitis (AD) is one of the common diseases seen at the dermatology clinic. A major complaint and clinical feature among AD patients is dryness of the skin and this has led to moisturisers being a major part of the treatment of AD. Studies of skin biophysical properties in AD patients reveal decreased hydration and increased trans epidermal water loss (TEWL). A variety of moisturisers are available, and they all claim to be effective at moisturising the skin in patients with AD. Studies documenting their proven efficacy have been carried out in temperate and non-tropical climates. The tropical climate in Nigeria differs considerably, with her hot and humid environment and temperature ranging between 25-40ยฐC. There is a dearth of literature documenting the tolerability and effectiveness of moisturisers in this setting. Topicremยฎ, one of the moisturisers available for use in management of AD is a new product in the Nigerian market. The product is a fluid and non-oily emulsion with a high moisturizing and lipid-replenishing power that instantly penetrates the skin without feeling sticky, thereby conferring 24-hour hydration following daily use. It has been used and validated successfully in other climes; however, it is yet to be clinically tested in Nigeria. The aim of this study, therefore, is to compare the recovery of skin hydration and normalization of TEWL in AD patients by Topicremยฎ, with the use of a validated moisturising lotion.Aim: To assess the efficacy of two moisturisers in restoring hydration, skin pH and Trans Epidermal Water Loss (TEWL) of patients with Atopic Dermatitis.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202209711529835
Non-Device Trial

